title: Outcome of delivery among HIV positive mothers at Aminu Kano Teaching Hospital, Kano.
abstract: BACKGROUND
  If a HIV positive mother delivers in a health facility, interventions can be effected to reduce the risk of transmission of HIV to the baby The study was done to evaluate the interventions offered to HIV positive women who delivered at Aminu Kano Teaching Hospital (AKTH) Kano.
  
  
  METHODS
  Retrospective review of the case records of all HIV positive patients that delivered at AKTH over a 27 month period (October 2003 to December 2005) was used.
  
  
  RESULTS
  There were 4922 deliveries out of which 125 were HIV positive, giving a prevalence rate of 2.54%. Most (75.2%) of the patients received Nevirapine alone in labour, 20.8% received a combination of antiretroviral drugs while 4% received none because their records were not available. Majority (88%) of the patients had spontaneous vaginal delivery, 10.4% by elective CS and 1.6% by emergency CS. There was no maternal death but 3.2% of the babies were stillbirths. All the babies received a single dose of Nevirapine. Most (96%) mothers chose exclusive breast milk substitute.
  
  
  CONCLUSIONS
  HIV positive mothers need to deliver in health facilities to receive the full compliment of care they deserve. Highly Active Antiretroviral therapy (HAART) should be introduced, as it is more effective for PMTCT.
authors.affiliation: Department of Obstetrics and Gynaecology Aminu Kano Teaching Hospital, Kano. jtukur@yahoo.com
authors.forename: J
authors.initials: J
authors.lastname: Tukur
authors.forename: H
authors.initials: H
authors.lastname: Galadanci
authors.forename: S I
authors.initials: SI
authors.lastname: Adeleke
authors.forename: M
authors.initials: M
authors.lastname: Mukhtar-Yola
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D003376:Counseling; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission*; D006784:Hospitals, Teaching; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019829:Nevirapine / Q000627:therapeutic use; D009549:Nigeria / Q000453:epidemiology; D017063:Outcome Assessment, Health Care; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D011256:Pregnancy Outcome; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine